122 completed, 52 recruiting, 42 unknown, 13 terminated. 261 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 261 | Completed 122, Recruiting 52, Unknown 42, Terminated 13, Active not recruiting 12, Not yet recruiting 9, Withdrawn 8, Enrolling by invitation 3 |
Follow Bladder Cancer: new trials by email Literature Review of Bladder Cancer trials Research Report on Bladder Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder Cancer AI Uro-Cam - Bladder Cancer | Not applicable | Not yet recruiting | Chinese University of Hong Kong | 60 | 2028-07-31 | 2026-07-22 |
| Role of ERBT Plus Intravesical BCG in Intermediate-Risk or High-Risk NMBC Conventional Transurethral Resection of Bladder Tumour, Transurethral En Bloc Resection of Bladder Tumour - Bladder Cancer | Not applicable | Recruiting | Chinese University of Hong Kong | 732 | 2026-10-19 | 2026-10-27 |
| Hyperthermic Intravesical Chemotherapy (HIVEC) in BCG-Non-Responsive High-Grade NMIBC Patients Hyperthermic Intravesical Chemotherapy (HIVEC) - Non Muscle Invasive Bladder Cancer, Bladder Cancer | Not applicable | Not yet recruiting | AC.TA. S.r.l. | 50 | 2026-10-15 | 2026-05-06 |
| Acupuncture and Exercise for EV-Pembro-Induced Peripheral Neuropathy Acupuncture, Exercise - Metastatic Bladder Cancer, Peripheral Neuropathy | Not applicable | Recruiting | Dana-Farber Cancer Institute | 20 | 2026-09-03 | 2026-10-26 |
| REtrieval of Transurethrally Resected Intact En-bloc Vesical Tumors Using a Retrieval Device for Bladder Tumors CURTIS retrieval device - Bladder Cancer, Bladder Cancer TNM Staging Primary Tumor (T) T1 | Not applicable | Not yet recruiting | Ludwig-Maximilians - University of Munich | 75 | 2026-09-01 | 2026-08-17 |
| Feasibility of HISA During TURBT for NMIBC HISA - Bladder Cancer, Bladder (Urothelial, Transitional Cell) Cancer Resectable (Pre-Cystectomy) | Not applicable | Not yet recruiting | CAMC Health System | 40 | 2026-08-15 | 2026-09-14 |
| Active Surveillance Versus Adjuvant Intravesical Chemotherapy in Liquid Biopsy-Defined Low-Shedding Intermediate-Risk NMIBC Active Surveillance, Adjuvant Intravesical Chemotherapy - Bladder Cancer, Non-Muscle-Invasive Bladder Cancer (NMIBC) | Not applicable | Recruiting | Tianjin Medical University Second Hospital | 670 | 2026-08-10 | 2026-10-09 |
| AI-Guided TURBT for Bladder Cancer AI Navigation Planning System - Bladder Cancer | Not applicable | Not yet recruiting | Fudan University | 170 | 2026-08-01 | 2026-07-27 |
| Prehabilitation in High-risk Oncologic Surgery Multidisciplinary Prehabilitation Program - Pancreatic Cancer, Colo-rectal Cancer | Not applicable | Recruiting | Fox Chase Cancer Center | 180 | 2026-07-15 | 2026-09-21 |
| Relevance of the Urine Bacterial Culture Performed Before TransUrethral Resection of the Bladder for Post-operative Febrile Urinary Tract Infections Prevention: a Non-inferiority Randomized Controlled Trial Urine bacterial Culture (UC), No intervention before TURB surgery - Bladder Cancer, Transurethral Resection of the Bladder | Not applicable | Recruiting | Poitiers University Hospital | 2600 | 2026-06-29 | 2026-09-04 |
| A Study of a Side Effects and Resource Navigation Program for People With Cancer Immunotherapy CARE Program - Kidney Cancer, Bladder Cancer | Not applicable | Recruiting | Memorial Sloan Kettering Cancer Center | 200 | 2026-06-09 | 2026-10-20 |
| Comprehensive Optimization At-time of Radical Cystectomy Intervention Preop Intervention and Monitored Recovery, Usual Care - Bladder Cancer, Radical Cystectomy | Not applicable | Withdrawn | University of Texas Southwestern Medical Center | 2026-05-01 | 2026-05-27 | |
| Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors PC2: Primary Care Connect - Cancer, Breast Cancer Early Stage Breast Cancer (Stage 1-3) | Not applicable | Enrolling by invitation | Rutgers, The State University of New Jersey | 266 | 2026-04-24 | 2026-07-10 |
| Randomized Trial of stAndard of Care With or Without Metastases-directed Stereotactic Body Radiation Therapy in Patients Affected by Oligometastatic uRothelial carcinomA SBRT - Bladder Cancer, Urothelial Carcinoma (UC) | Not applicable | Recruiting | Istituto Clinico Humanitas | 44 | 2026-02-16 | 2026-04-30 |
| Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial Physical Activity Promotion Intervention - Breast Cancer, Cervical Cancer | Not applicable | Recruiting | Medical College of Wisconsin | 50 | 2026-02-07 | 2026-08-20 |
| Evaluation of the Clinical Utility of Online Adaptive Radiotherapy in Bladder Cancer (BLADAPT-GETUG V11) Adaptive radiotherapy, standard radiotherapy - Bladder Cancer | Not applicable | Not yet recruiting | Institut du Cancer de Montpellier - Val d'Aurelle | 120 | 2026-01-15 | 2025-12-15 |
| Supporting Sexual Health in Bladder Cancer Patients: A Sequential Mixed-Methods Intervention Study Sexological Support - Bladder Cancer, Non-Muscle-Invasive Bladder Cancer (NMIBC) | Not applicable | Recruiting | University of Aarhus | 30 | 2026-01-01 | 2026-01-14 |
| Clinical Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy Ureteral Stent Placement, No Ureteral Stent, Indocyanine Green with Fluorescence Imaging - Bladder Cancer, Muscle-Invasive Bladder Carcinoma | Not applicable | Recruiting | Thomas Jefferson University | 70 | 2025-12-23 | 2026-02-17 |
| Validity of Parametric MRI Using VIRADS Gadolinium - Bladder Cancer | Not applicable | Recruiting | Assiut University | 58 | 2025-12-01 | 2025-10-02 |
| Home Intravenous Fluid Infusion After Undergoing Radical Cystectomy Intravenous fluids, ERAS - Bladder Cancer, Muscle Invasive Bladder Cancer (MIBC) | Not applicable | Recruiting | Johns Hopkins University | 130 | 2025-11-01 | 2025-11-20 |
Showing 20 of 261. Sign in to see all of them.
Urinary Bladder Neoplasms (261) · Prostatic Neoplasms (35) · Lung Neoplasms (23) · Breast Neoplasms (20) · Kidney Neoplasms (20) · Colorectal Neoplasms (15) · Ovarian Neoplasms (13) · Colonic Neoplasms (11) · Neoplasms (11) · Non-Muscle Invasive Bladder Neoplasms (11) · Pancreatic Neoplasms (11) · Uterine Cervical Neoplasms (11) · Carcinoma, Renal Cell (10) · Carcinoma, Transitional Cell (10) · Esophageal Neoplasms (10)
Female Urogenital Diseases (261) · Female Urogenital Diseases and Pregnancy Complications (261) · Male Urogenital Diseases (261) · Neoplasms by Site (261) · Urogenital Diseases (261) · Urogenital Neoplasms (260) · Urologic Diseases (260) · Urologic Neoplasms (258) · Urinary Bladder Diseases (256) · Neoplasms (250) · Pathological Conditions, Signs and Symptoms (53) · Genital Diseases (48) · Neoplasms by Histologic Type (47) · Neoplasms, Glandular and Epithelial (41) · Genital Diseases, Male (39)
Cystectomy (6) · Cystoscopy (5) · Standard of Care (5) · Blood Specimen Collection (4) · Exercise (4) · Multiparametric Magnetic Resonance Imaging (4) · Transurethral Resection of Bladder (4) · Diet Therapy (3) · Gemcitabine (3) · Radiotherapy, Intensity-Modulated (3) · Surgical Procedures, Operative (3) · Watchful Waiting (3) · Anesthesia, General (2) · Cisplatin (2) · Drug Therapy (2)
Mansoura University (13) · Chinese University of Hong Kong (7) · Memorial Sloan Kettering Cancer Center (5) · The First Affiliated Hospital with Nanjing Medical University (5) · Copenhagen University Hospital, Rigshospitalet (4) · Icahn School of Medicine at Mount Sinai (4) · Johns Hopkins University (4) · RenJi Hospital (4) · UNC Lineberger Comprehensive Cancer Center (4) · University of Aarhus (4) · Brigham and Women's Hospital (3) · Jørgen Bjerggaard Jensen (3) · Seoul National University Hospital (3) · The Affiliated Hospital of Qingdao University (3) · Tianjin Medical University Second Hospital (3)
United States (88) · China (26) · Egypt (21) · Denmark (18) · France (13) · Italy (11) · Canada (9) · Netherlands (8) · South Korea (8) · Spain (7) · United Kingdom (7) · Germany (6) · Hong Kong (6) · Switzerland (4) · Turkey (Türkiye) (4)
Amr A Elsawy (6) · Yair Lotan, MD (3) · Ahmed Mosbah, MD (2) · Andrew Rosenkrantz, MD (2) · Eugene Lee, MD (2) · Haitao Niu, PhD (2) · Jeremy YC Teoh, MBBS (2) · Nihal Mohamed, PhD (2) · Qiang Lu, PhD (2) · Sam S Chang, MD (2) · Abai Xu, doctor (1) · Abdullah Demirtas, MD (1) · Adrian S Ishkanian, MD (1) · Ahmed M Elshal, MD (1)
PMID 24373477, PMID 25150172, PMID 11229684, PMID 11923603, PMID 12136861, PMID 12525530, PMID 15093567, PMID 15199091, PMID 1612951, PMID 16685271, PMID 17993339, PMID 18295861, PMID 18803341, PMID 18947938, PMID 19222048, PMID 19508716, PMID 20238325, PMID 20303878, PMID 20429726, PMID 20689253, PMID 21272338, PMID 21458150, PMID 22050425, PMID 22067707, PMID 22444831, PMID 22543204, PMID 22658217, PMID 22877502, PMID 23052535, PMID 23199641, PMID 23290142, PMID 23538237, PMID 24390799, PMID 24423437, PMID 24475186, PMID 24681333, PMID 24821357, PMID 24840856, PMID 25035206, PMID 25220842, PMID 25651787, PMID 25840895, PMID 26091833, PMID 26293795, PMID 26433570, PMID 26644527, PMID 26742998, PMID 26880857, PMID 26882087, PMID 27123543
2019 (1), K01CA255414 (1), P30CA016056 (1), P30CA042014 (1), P30CA046934 (1), P50CA244688 (1), R01CA129226 (1), R01CA201709 (1), R01CA254730 (1), R01NR016990 (1), R21CA114523 (1), R21CA167800 (1), R21CA212628 (1), R21NR018942 (1), R37CA248774 (1)